OTC Healthcare in Middle East and Africa to 2014

Introduction

This databook provides key data and information on the OTC healthcare market covering seven countries in the Middle East and Africa region. This report is a comprehensive resource for market, category and segment level data including value, volume, distribution and company share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

*Contains information on:analgesics,medicated skinproduct,topicalOTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits

*Market, category and segment level information on value and volume with historic (2004-09) and forecast (2010-14) data

*Category level company share as well as distribution share information for 2008 and 2009

*Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights

The market for OTC healthcare in Middle East and Africa increased at a compound annual growth rate of 7.6% between 2004 and 2009.

The traditional medicines category led the OTC healthcare market in Middle East and Africa, accounting for a share of 25.5%.

The leading players in the Middle East and African OTC healthcare market include GlaxoSmithKline Plc, Johnson & Johnson and Novartis AG.

Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Middle East and Africa

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements


Report Highlights

[Cerrar las informaciones del articulo de mercado]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary market level: OTC healthcare 2
Summary category level: analgesics 3
Summary category level: topical OTC medicines 4
Summary category level: cough and cold preparations 5
Summary category level: indigestion preparations 6
Summary category level: medicated skin products 7
Summary category level: first aid kits 8
Summary category level: other OTC healthcare products 9
Summary category level: plasters & bandages 10
Summary category level: traditional medicines 11
Summary category level: vitamins and minerals 12
Chapter 2 Introduction 13
What is this report about? 13
How to use this report 13
Market definition 14
Chapter 3 Overview 28
Value Analysis 28
Chapter 4 Middle East and Africa OTC Healthcare: Market Overview 29
Value analysis (US Dollar), 2004?09 29
Value analysis (US Dollar), 2009?14 31
Company share analysis 34
Distribution analysis 37
Chapter 5 Leading Company Profiles 39
GlaxoSmithKline Plc 39
Johnson & Johnson 42
Chapter 6 Category Analysis: Analgesics 44
Value analysis (US Dollar), 2004?09 44
Value analysis (US Dollar), 2009?14 45
Company share analysis 47
Distribution analysis 50
Chapter 7 Category Analysis: Topical OTC Medicines 52
Value analysis (US Dollar), 2004?09 52
Value analysis (US Dollar), 2009?14 53
Company share analysis 55
Distribution analysis 58
Chapter 8 Category Analysis: Cough and Cold Preparations 60
Value analysis (US Dollar), 2004?09 60
Value analysis (US Dollar), 2009?14 61
Company share analysis 63
Distribution analysis 66
Chapter 9 Category Analysis: Indigestion Preparations 68
Value analysis (US Dollar), 2004?09 68
Value analysis (US Dollar), 2009?14 69
Company share analysis 71
Distribution analysis 74
Chapter 10 Category Analysis: Medicated Skin Products 76
Value analysis (US Dollar), 2004?09 76
Value analysis (US Dollar), 2009?14 77
Company share analysis 79
Distribution analysis 82
Chapter 11 Category Analysis: First Aid Kits 84
Value analysis (US Dollar), 2004?09 84
Value analysis (US Dollar), 2009?14 85
Company share analysis 86
Distribution analysis 88
Chapter 12 Category Analysis: Other OTC Healthcare Products 90
Value analysis (US Dollar), 2004?09 90
Value analysis (US Dollar), 2009?14 91
Company share analysis 93
Distribution analysis 96
Chapter 13 Category Analysis: Plasters & Bandages 98
Value analysis (US Dollar), 2004?09 98
Value analysis (US Dollar), 2009?14 99
Company share analysis 101
Distribution analysis 104
Chapter 14 Category Analysis: Traditional Medicines 106
Value analysis (US Dollar), 2004?09 106
Value analysis (US Dollar), 2009?14 107
Company share analysis 108
Distribution analysis 111
Chapter 15 Category Analysis: Vitamins and Minerals 113
Value analysis (US Dollar), 2004?09 113
Value analysis (US Dollar), 2009?14 114
Company share analysis 116
Distribution analysis 119
Chapter 16 Research Methodology 121
Methodology overview 121
Secondary research 122
Market modeling 123
Creating an initial data model 123
Revising the initial data model 123
Creating a final estimate 124
Creating demographic value splits 124
Primary research 124
Data finalization 125
Ongoing research 125
Chapter 17 Appendix 126
Future readings 126
How to contact experts in your industry 126
Disclaimer 126

LIST OF FIGURES
Figure 1: OTC healthcare, Middle East and Africa, value by category ($m), 2004?14 32
Figure 2: OTC healthcare, Middle East and Africa, category growth comparison, by value, 2004?14 33
Figure 3: OTC healthcare, Middle East and Africa, company share (top five companies) by value (%), 2008?09 36
Figure 4: OTC healthcare, Middle East and Africa, distribution channels by value (%), 2008?09 38
Figure 5: Analgesics, Middle East and Africa, value by segment ($m), 2004?14 46
Figure 6: Analgesics, Middle East and Africa, category growth comparison, by value, 2004?14 46
Figure 7: Analgesics, Middle East and Africa, company share (top five companies) by value (%), 2008?09 49
Figure 8: Analgesics, Middle East and Africa, distribution channels by value (%), 2008?09 51
Figure 9: Topical OTC medicines, Middle East and Africa, value by segment ($m), 2004?14 54
Figure 10: Topical OTC medicines, Middle East and Africa, category growth comparison, by value, 2004?14 54
Figure 11: Topical OTC medicines, Middle East and Africa, company share (top five companies) by value (%), 2008?09 57
Figure 12: Topical OTC medicines, Middle East and Africa, distribution channels by value (%), 2008?09 59
Figure 13: Cough and cold preparations, Middle East and Africa, value by segment ($m), 2004?14 62
Figure 14: Cough and cold preparations, Middle East and Africa, category growth comparison, by value, 2004?14 62
Figure 15: Cough and cold preparations, Middle East and Africa, company share (top five companies) by value (%), 2008?09 65
Figure 16: Cough and cold preparations, Middle East and Africa, distribution channels by value (%), 2008?09 67
Figure 17: Indigestion preparations, Middle East and Africa, value by segment ($m), 2004?14 70
Figure 18: Indigestion preparations, Middle East and Africa, category growth comparison, by value, 2004?14 70
Figure 19: Indigestion preparations, Middle East and Africa, company share (top five companies) by value (%), 2008?09 73
Figure 20: Indigestion preparations, Middle East and Africa, distribution channels by value (%), 2008?09 75
Figure 21: Medicated skin products, Middle East and Africa, value by segment ($m), 2004?14 78
Figure 22: Medicated skin products, Middle East and Africa, category growth comparison, by value, 2004?14 78
Figure 23: Medicated skin products, Middle East and Africa, company share (top five companies) by value (%), 2008?09 81
Figure 24: Medicated skin products, Middle East and Africa, distribution channels by value (%), 2008?09 83
Figure 25: First aid kits, Middle East and Africa, value ($m), 2004?14 85
Figure 26: First aid kits, Middle East and Africa, company share (top five companies) by value (%), 2008?09 87
Figure 27: First aid kits, Middle East and Africa, distribution channels by value (%), 2008?09 89
Figure 28: Other OTC healthcare products, Middle East and Africa, value by segment ($m), 2004?14 92
Figure 29: Other OTC healthcare products, Middle East and Africa, category growth comparison, by value, 2004?14 92
Figure 30: Other OTC healthcare products, Middle East and Africa, company share (top five companies) by value (%), 2008?09 95
Figure 31: Other OTC healthcare products, Middle East and Africa, distribution channels by value (%), 2008?09 97
Figure 32: Plasters & bandages, Middle East and Africa, value by segment ($m), 2004?14 100
Figure 33: Plasters & bandages, Middle East and Africa, category growth comparison, by value, 2004?14 100
Figure 34: Plasters & bandages, Middle East and Africa, company share (top five companies) by value (%), 2008?09 103
Figure 35: Plasters & bandages, Middle East and Africa, distribution channels by value (%), 2008?09 105
Figure 36: Traditional medicines, Middle East and Africa, value ($m), 2004?14 107
Figure 37: Traditional medicines, Middle East and Africa, company share (top five companies) by value (%), 2008?09 110
Figure 38: Traditional medicines, Middle East and Africa, distribution channels by value (%), 2008?09 112
Figure 39: Vitamins and minerals, Middle East and Africa, value by segment ($m), 2004?14 115
Figure 40: Vitamins and minerals, Middle East and Africa, category growth comparison, by value, 2004?14 115
Figure 41: Vitamins and minerals, Middle East and Africa, company share (top five companies) by value (%), 2008?09 118
Figure 42: Vitamins and minerals, Middle East and Africa, distribution channels by value (%), 2008?09 120
Figure 43: Annual data review process 122

LIST OF TABLES
Table 1: OTC healthcare category definitions 15
Table 2: OTC healthcare distribution channels 17
Table 3: OTC healthcare, Middle East and Africa, value (country-wise), 2004?09 ($m) 28
Table 4: OTC healthcare, Middle East and Africa, value (country-wise) forecast, 2009?14 ($m) 28
Table 5: OTC healthcare, Middle East and Africa, value by category ($m), 2004?09 30
Table 6: OTC healthcare, Middle East and Africa, value forecast by category ($m), 2009?14 31
Table 7: OTC healthcare, Middle East and Africa, company share (top 20 companies) by value (%), 2008?09 34
Table 8: OTC healthcare, Middle East and Africa, value by company ($m), 2008?09 35
Table 9: OTC healthcare, Middle East and Africa, distribution channels by value (%), 2008?09 37
Table 10: OTC healthcare, Middle East and Africa, value by distribution channel ($m), 2008?09 37
Table 11: GlaxoSmithKline Plc key facts 39
Table 12: Johnson & Johnson key facts 42
Table 13: Analgesics, Middle East and Africa, value by segment ($m), 2004?09 44
Table 14: Analgesics, Middle East and Africa, value forecast by segment ($m), 2009?14 45
Table 15: Analgesics, Middle East and Africa, company share by value (%), 2008?09 47
Table 16: Analgesics, Middle East and Africa, value by company ($m), 2008?09 48
Table 17: Analgesics, Middle East and Africa, distribution channels by value (%), 2008?09 50
Table 18: Analgesics, Middle East and Africa, value by distribution channel ($m), 2008?09 50
Table 19: Topical OTC medicines, Middle East and Africa, value by segment ($m), 2004?09 52
Table 20: Topical OTC medicines, Middle East and Africa, value forecast by segment ($m), 2009?14 53
Table 21: Topical OTC medicines, Middle East and Africa, company share by value (%), 2008?09 55
Table 22: Topical OTC medicines, Middle East and Africa, value by company ($m), 2008?09 56
Table 23: Topical OTC medicines, Middle East and Africa, distribution channels by value (%), 2008?09 58
Table 24: Topical OTC medicines, Middle East and Africa, value by distribution channel ($m), 2008?09 58
Table 25: Cough and cold preparations, Middle East and Africa, value by segment ($m), 2004?09 60
Table 26: Cough and cold preparations, Middle East and Africa, value forecast by segment ($m), 2009?14 61
Table 27: Cough and cold preparations, Middle East and Africa, company share (top 20 companies) by value (%), 2008?09 63
Table 28: Cough and cold preparations, Middle East and Africa, value by company ($m), 2008?09 64
Table 29: Cough and cold preparations, Middle East and Africa, distribution channels by value (%), 2008?09 66
Table 30: Cough and cold preparations, Middle East and Africa, value by distribution channel ($m), 2008?09 66
Table 31: Indigestion preparations, Middle East and Africa, value by segment ($m), 2004?09 68
Table 32: Indigestion preparations, Middle East and Africa, value forecast by segment ($m), 2009?14 69
Table 33: Indigestion preparations, Middle East and Africa, company share (top 20 companies) by value (%), 2008?09 71
Table 34: Indigestion preparations, Middle East and Africa, value by company ($m), 2008?09 72
Table 35: Indigestion preparations, Middle East and Africa, distribution channels by value (%), 2008?09 74
Table 36: Indigestion preparations, Middle East and Africa, value by distribution channel ($m), 2008?09 74
Table 37: Medicated skin products, Middle East and Africa, value by segment ($m), 2004?09 76
Table 38: Medicated skin products, Middle East and Africa, value forecast by segment ($m), 2009?14 77
Table 39: Medicated skin products, Middle East and Africa, company share (top 20 companies) by value (%), 2008?09 79
Table 40: Medicated skin products, Middle East and Africa, value by company ($m), 2008?09 80
Table 41: Medicated skin products, Middle East and Africa, distribution channels by value (%), 2008?09 82
Table 42: Medicated skin products, Middle East and Africa, value by distribution channel ($m), 2008?09 82
Table 43: First aid kits, Middle East and Africa, value ($m), 2004?09 84
Table 44: First aid kits, Middle East and Africa, value forecast ($m), 2009?14 85
Table 45: First aid kits, Middle East and Africa, company share by value (%), 2008?09 86
Table 46: First aid kits, Middle East and Africa, value by company ($m), 2008?09 87
Table 47: First aid kits, Middle East and Africa, distribution channels by value (%), 2008?09 88
Table 48: First aid kits, Middle East and Africa, value by distribution channel ($m), 2008?09 88
Table 49: Other OTC healthcare products, Middle East and Africa, value by segment ($m), 2004?09 90
Table 50: Other OTC healthcare products, Middle East and Africa, value forecast by segment ($m), 2009?14 91
Table 51: Other OTC healthcare products, Middle East and Africa, company share (top 20 companies) by value (%), 2008?09 93
Table 52: Other OTC healthcare products, Middle East and Africa, value by company ($m), 2008?09 94
Table 53: Other OTC healthcare products, Middle East and Africa, distribution channels by value (%), 2008?09 96
Table 54: Other OTC healthcare products, Middle East and Africa, value by distribution channel ($m), 2008?09 96
Table 55: Plasters & bandages, Middle East and Africa, value by segment ($m), 2004?09 98
Table 56: Plasters & bandages, Middle East and Africa, value forecast by segment ($m), 2009?14 99
Table 57: Plasters & bandages, Middle East and Africa, company share by value (%), 2008?09 101
Table 58: Plasters & bandages, Middle East and Africa, value by company ($m), 2008?09 102
Table 59: Plasters & bandages, Middle East and Africa, distribution channels by value (%), 2008?09 104
Table 60: Plasters & bandages, Middle East and Africa, value by distribution channel ($m), 2008?09 104
Table 61: Traditional medicines, Middle East and Africa, value ($m), 2004?09 106
Table 62: Traditional medicines, Middle East and Africa, value forecast ($m), 2009?14 107
Table 63: Traditional medicines, Middle East and Africa, company share by value (%), 2008?09 108
Table 64: Traditional medicines, Middle East and Africa, value by company ($m), 2008?09 109
Table 65: Traditional medicines, Middle East and Africa, distribution channels by value (%), 2008?09 111
Table 66: Traditional medicines, Middle East and Africa, value by distribution channel ($m), 2008?09 111
Table 67: Vitamins and minerals, Middle East and Africa, value by segment ($m), 2004?09 113
Table 68: Vitamins and minerals, Middle East and Africa, value forecast by segment ($m), 2009?14 114
Table 69: Vitamins and minerals, Middle East and Africa, company share by value (%), 2008?09 116
Table 70: Vitamins and minerals, Middle East and Africa, value by company ($m), 2008?09 117
Table 71: Vitamins and minerals, Middle East and Africa, distribution channels by value (%), 2008?09 119
Table 72: Vitamins and minerals, Middle East and Africa, value by distribution channel ($m), 2008?09 119


[Cerrar la tabla de contenidos]